Caplin Point Laboratories Management
Management criteria checks 3/4
Caplin Point Laboratories' CEO is Sridhar Ganesan, appointed in Mar 2015, has a tenure of 9.33 years. total yearly compensation is ₹8.70M, comprised of 95.4% salary and 4.6% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth ₹132.93M. The average tenure of the management team and the board of directors is 8.4 years and 6 years respectively.
Key information
Sridhar Ganesan
Chief executive officer
₹8.7m
Total compensation
| CEO salary percentage | 95.4% |
| CEO tenure | 9.3yrs |
| CEO ownership | 0.1% |
| Management average tenure | 8.4yrs |
| Board average tenure | 6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | ₹5b |
| Dec 31 2023 | n/a | n/a | ₹4b |
| Sep 30 2023 | n/a | n/a | ₹4b |
| Jun 30 2023 | n/a | n/a | ₹4b |
| Mar 31 2023 | ₹9m | ₹8m | ₹4b |
| Dec 31 2022 | n/a | n/a | ₹4b |
| Sep 30 2022 | n/a | n/a | ₹3b |
| Jun 30 2022 | n/a | n/a | ₹3b |
| Mar 31 2022 | ₹6m | ₹5m | ₹3b |
| Dec 31 2021 | n/a | n/a | ₹3b |
| Sep 30 2021 | n/a | n/a | ₹3b |
| Jun 30 2021 | n/a | n/a | ₹3b |
| Mar 31 2021 | ₹6m | ₹5m | ₹2b |
| Dec 31 2020 | n/a | n/a | ₹2b |
| Sep 30 2020 | n/a | n/a | ₹2b |
| Jun 30 2020 | n/a | n/a | ₹2b |
| Mar 31 2020 | ₹6m | ₹6m | ₹2b |
| Dec 31 2019 | n/a | n/a | ₹2b |
| Sep 30 2019 | n/a | n/a | ₹2b |
| Jun 30 2019 | n/a | n/a | ₹2b |
| Mar 31 2019 | ₹6m | ₹6m | ₹2b |
| Dec 31 2018 | n/a | n/a | ₹2b |
| Sep 30 2018 | n/a | n/a | ₹2b |
| Jun 30 2018 | n/a | n/a | ₹1b |
| Mar 31 2018 | ₹6m | ₹6m | ₹1b |
Compensation vs Market: Sridhar's total compensation ($USD104.18K) is below average for companies of similar size in the Indian market ($USD448.43K).
Compensation vs Earnings: Sridhar's compensation has increased by more than 20% in the past year.
CEO
Sridhar Ganesan (69 yo)
9.3yrs
Tenure
₹8,700,000
Compensation
Dr. Sridhar Ganesan has been the Managing Director of Caplin Point Laboratories Ltd since March 28, 2015. Dr. Ganesan has been Whole Time Director of Caplin Point Laboratories Ltd since August 25, 2014. He...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Whole Time Director | 9.3yrs | ₹8.70m | 0.12% ₹ 132.9m | |
| Chief Financial Officer | 8.4yrs | ₹9.70m | 0.020% ₹ 22.2m | |
| Chief Operating Officer | 12.9yrs | ₹1.90m | 11.84% ₹ 13.1b | |
| General Counsel | 1.9yrs | ₹2.30m | no data | |
| Deputy Chief Financial Officer | no data | no data | no data | |
| Head of Marketing - Latam Business | no data | no data | 11.91% ₹ 13.2b | |
| Chief Transformation & Digital Officer | less than a year | no data | no data |
8.4yrs
Average Tenure
Experienced Management: 524742's management team is seasoned and experienced (8.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Whole Time Director | 10.4yrs | ₹8.70m | 0.12% ₹ 132.9m | |
| Non-Executive Non-Independent Chairman | 34.3yrs | no data | 18.64% ₹ 20.7b | |
| Non-Executive Independent Director | 7.7yrs | ₹160.00k | no data | |
| Non-Executive Independent Director | 4.3yrs | ₹100.00k | no data | |
| Non-Executive Independent Director | 1.8yrs | ₹40.00k | no data | |
| Independent Non-Executive Director | 1.8yrs | ₹60.00k | 0.000090% ₹ 99.8k |
6.0yrs
Average Tenure
71.5yo
Average Age
Experienced Board: 524742's board of directors are considered experienced (6 years average tenure).